Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Microliter dispensing pumps deliver accurate low-volume dosing to support laboratory, diagnostic, and industrial fluid ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...

The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

A significant proportion of repeated pregnancy failures can be attributed to chromosomal abnormalities—either inherited from one of the parents or arising spontaneously in the embryo.

Male infertility can impact pregnancy chances more than many realise. An expert explains key causes, genetic factors, warning ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.